Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival

Surg Oncol. 2017 Sep;26(3):324-330. doi: 10.1016/j.suronc.2017.06.004. Epub 2017 Jun 22.

Abstract

Background: Minimally invasive (MI) gastrectomy has become increasingly common as a resection technique for gastric cancer; however, data are limited regarding peri-operative morbidity, oncologic outcomes and long-term survival, particularly in the Western patient population.

Study design: The 2010-2012 National Cancer Data Base was queried for adult patients who underwent gastrectomy for localized, intestinal-type gastric adenocarcinoma. Patients were classified by surgical approach (MI vs. open gastrectomy) on an intent-to-treat basis. Groups were propensity score matched using a 1:1 nearest neighbor algorithm, and outcomes were compared. Survival was estimated using the Kaplan-Meier method.

Results: Among 5420 patients, 1423 (26%) underwent MI gastrectomy. Following adjustment with propensity matching, all baseline characteristics were highly similar between 1175 patients in each treatment group. Between propensity-matched groups, MI gastrectomy patients had similar rates of margin-negative resections (91 vs. 90%, p = 0.447), median lymph node harvest (16 vs. 15, p = 0.104), and utilization of adjuvant therapies (28 vs. 28%, p = 0.748). MI gastrectomy was associated with shorter hospital stay (8 vs. 9 days, p < 0.001) without an increase in unplanned readmissions (7 vs. 6%, p = 0.456) or 30-day mortality (2 vs. 3%, p = 0.655). There was no difference in 3-year overall survival (50 vs. 55%, p = 0.359).

Conclusions: On a national level, MI gastrectomy for gastric cancer appears to be associated with similar perioperative and long-term outcomes compared to the traditional open approach. While prospective studies remain essential, these data provide greater equipoise for ongoing trials and institutional efforts to further implement and evaluate this technique.

Keywords: Gastrectomy; Gastric cancer; Laparoscopic gastrectomy; Minimally invasive gastrectomy; National cancer database; Survival.

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Adult
  • Aged
  • Chemotherapy, Adjuvant / mortality
  • Chemotherapy, Adjuvant / statistics & numerical data
  • Female
  • Gastrectomy / methods*
  • Gastrectomy / mortality
  • Humans
  • Laparoscopy / methods*
  • Laparoscopy / mortality
  • Length of Stay / statistics & numerical data
  • Lymph Node Excision / methods
  • Lymph Node Excision / mortality
  • Lymphatic Metastasis
  • Male
  • Propensity Score
  • Puerto Rico / epidemiology
  • Radiotherapy, Adjuvant / mortality
  • Radiotherapy, Adjuvant / statistics & numerical data
  • Retrospective Studies
  • Robotic Surgical Procedures / methods*
  • Robotic Surgical Procedures / mortality
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Survival Analysis
  • Treatment Outcome
  • Tumor Burden
  • United States / epidemiology